MARKET

LEXXW

LEXXW

LEXARIA BIOSCIEN
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.150
+0.017
+0.80%
Closed 16:00 04/21 EDT
OPEN
2.111
PREV CLOSE
2.150
HIGH
2.250
LOW
2.111
VOLUME
4.58K
TURNOVER
--
52 WEEK HIGH
4.219
52 WEEK LOW
0.6000
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
Lexaria Commences Human Clinical Hypertension Study
(via TheNewswire)
TheNewswire.ca · 13h ago
Lexaria Appoints New Chief Financial Officer and Issues Consultant Warrants
(via TheNewswire)
TheNewswire.ca · 04/15 17:05
Lexaria's DehydraTECH(TM) Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network
(via TheNewswire)
TheNewswire.ca · 04/14 11:00
Lexaria Bioscience To Begin Applied Research And Development Programs Planned In 2021
Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, will begin important new applied research and development
Benzinga · 04/06 11:10
Lexaria to Evaluate DehydraTECH(TM) in Multiple New Markets
(via TheNewswire)
TheNewswire.ca · 04/06 11:05
Lexaria Bioscience Announces Results From Stability Testing; Says DehydraTECH CBD-Beverage Demonstrates 93.4% Potency One Year After Production
DehydraTECHTM CBD-Beverage Demonstrates 93.4% Potency One Year After Production Lexaria's Nanoemulsification Processing Technique Ensures Content Uniformity and Homogeneity of CBD Distribution
Benzinga · 03/24 11:08
Lexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD Beverages
(via TheNewswire)
TheNewswire.ca · 03/24 11:00
Lexaria to Present at the Benzinga Biotech Small Cap Conference on March 24, 2021 at 9:45 AM ET
Lexaria recently announced progress on its hypertension R&D program, consisting of three human clinical and two animal studies, as well as two studies in its antiviral drug evaluation program
ACCESSWIRE · 03/23 11:00
More
No Data
Learn about the latest financial forecast of LEXXW. Analyze the recent business situations of LEXARIA BIOSCIEN through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
  • All
  • Financials
  • Insiders
No Data

Webull offers kinds of Lexaria Bioscience Corp stock information, including NASDAQ:LEXXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXXW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LEXXW stock methods without spending real money on the virtual paper trading platform.